The frequency of three mitochondrial point mutations, 1555A-->G, 3243A-->G,
and 7445A-->G, known to be associated with hearing impairment, was examine
d using restriction fragment length polymorphism (RFLP) analysis in two Jap
anese groups: (1) 319 unrelated SNHL outpatients (including 21 with aminogl
ycoside antibiotic injection history), and (2) 140 cochlear implantation pa
tients (including 22 with aminoglycoside induced hearing lass). Approximate
ly 3% of the outpatients and 10% of the cochlear implantation patients had
the 1555A-->G mutation. The frequency was higher in the patients with a his
tory of aminoglycoside injection (outpatient group 33%, cochlear implantati
on group 59%). One outpatient (0.314%) had the 3243A-->G mutation, but no o
utpatients had the 7445A-->G mutation and neither were found in the cochlea
r implantation group. The significance of the 1555A-->G mutation, the most
prevalent mitochondrial mutation found in this study of a hearing impaired
population in Japan, among subjects with specific backgrounds, such as amin
oglycoside induced hearing loss, is evident.